Directive (EU) 2001/20
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
In forceTypedirectiveDate4 Apr 2001Since3 Oct 2001Articles24Versions held115Cited by249 documentsLast changed1 Jan 2022
- 1Scope
- 2Definitions
- 3Protection of clinical trial subjects
- 4Clinical trials on minors
- 5Clinical trials on incapacitated adults not able to give informed legal consent
- 6Ethics Committee
- 7Single opinion
- 8Detailed guidance
- 9Commencement of a clinical trial
- 10Conduct of a clinical trial
- 11Exchange of information
- 12Suspension of the trial or infringements
- 13Manufacture and import of investigational medicinal products
- 14Labelling
- 15Verification of compliance of investigational medicinal products with good clinical and manufacturing pract
- 16Notification of adverse events
- 17Notification of serious adverse reactions
- 18Guidance concerning reports
- 19General provisions
- 20
- 21
- 22Application
- 23Entry into force
- 24Addressees
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).